CrisprBits

Delhi, India Founded: 2020 • Age: 6 yrs
CRISPR-based diagnostic tests for diseases are developed.

About CrisprBits

CrisprBits is a Healthcare company based in Delhi (India) founded in 2020 by Bharat Jobanputra, Sunil Arora, Rajeev Kohli, Aditya Sarda, and Vijaya Chandru. CRISPR-based diagnostic tests for diseases are developed. CrisprBits has raised $3.45 million across 3 funding rounds from investors including VJ Technologies, Abilities India Pistons and Rings and Rajeev Kohli. The company has 41 employees. CrisprBits was last valued at $284.02 thousand in May 2022. Its Indian entity Crisprbits Private Limited reported revenue of β‚Ή1.12 Cr. CrisprBits offers products and services including CRISPR Diagnostics, Therapeutics Development, and Climate Applications. Its focus areas include Life Sciences, Genomics, Applied Genomics and Clinical Genomics.

Company details

CrisprBits was founded in 2020 in Delhi, India, within the biotechnology sector. Diagnostic tests utilizing CRISPR gene editing technology are provided for infectious diseases, inherited conditions, cancer detection, and genetic disease prediction. These tools are applied in animal and cell models, agriculture, biofuels production, therapeutic development, and industrial processes. Operations focus on advancing accessible diagnostics across healthcare and related fields.

  • Headquarters Delhi, India
  • Employees 41
  • Founders Bharat Jobanputra, Sunil Arora, Rajeev Kohli, Aditya Sarda, Vijaya Chandru
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website crisprbits.com
  • Social LinkedIn
  • Legal Name Crisprbits Private Limited
  • Date of Incorporation 19 Oct, 2020
  • Jurisdiction Delhi, India
Key Metrics
  • Annual Revenue
    ₹1.12 Cr

    FY 2026 · +35% YoY

  • Net Loss
    -₹2.30 Cr

    FY 2026 · -267% margin

  • EBITDA
    -₹3.59 Cr

    FY 2026 · -418% margin

  • Total Equity Funding
    $3.45M (USD)

    in 3 rounds

  • Latest Funding Round
    $3M (USD), Seed

    Nov 2025

  • Investors
  • Employee Count
    41

Products & Services of CrisprBits

CrisprBits offers a comprehensive portfolio of products and services, including CRISPR Diagnostics, Therapeutics Development, and Climate Applications.

CRISPR Diagnostics
Diagnostic Tools

Tests for infectious and inherited diseases using gene-editing technology.

Therapeutics Development
Gene Editing Services

Enables ex-vivo editing for CAR-T cells and iPSCs in healthcare.

Climate Applications
Agricultural Biotech

Applies CRISPR for crop disease resistance and drought tolerance.

Funding Insights of CrisprBits

CrisprBits has successfully raised a total of $3.45M across 3 strategic funding rounds. The most recent funding activity was a Seed round of $3 million completed in November 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $3.45M
  • Total Rounds 3
  • Last Round Seed β€” $3M
  • First Round $196,670

    (May 2022)

  • Investors Count 10

All 3 funding rounds of CrisprBits with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Nov 2025$3MSeed–Spectrum Impact
Feb 2023$250,000Seed––
May 2022$196,670Seed$284,020Abilities India Pistons and Rings
Valuation history

Last known valuation $284,020 (May 2022). 10 investors in total: 4 institutional and 6 angel.

Investors in CrisprBits

CrisprBits has secured backing from 10 investors, including institutional, angel, and venture fund investors. Prominent investors backing the company include VJ Technologies, Abilities India Pistons and Rings and Rajeev Kohli.

All
Venture Fund
Institutional
Angel
InvestorDescriptionFounded YearDomainLocation
Spectrum Impact is engaged in solving societal issues through investments.
spectrum-impact.org
Provider of x-ray inspection solutions
1987vjt.comBohemia, United States
Manufactures automotive pistons, rings, and casting parts for engine components.
aippistons.comGhaziabad, India
Manufacturers of batteries and DC power systems
hbl.in

Rajeev Kohli

unknown_e70db52654b841b79

Sunil Arora

unknown_303788457fce47208

Aditya Sarda

unknown_27a2f7ede2c74a708

Nancy M Khardori

unknown_fd0a7450ac5d4bf18

Vijay Chandru

unknown_6a0bf957e22f4a679

Rajendra Gogri

unknown_0c3046cd483d4a41b
Premium access

Investor details for CrisprBits

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Crisprbits Private Limited (CrisprBits)

Crisprbits Private Limited is the primary company behind CrisprBits. The board of Crisprbits Private Limited currently have 4 directors; the longest-serving is Sunil Arora, appointed in 2020. 3 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Sunil Arora
DIN 01017075
Director19 Oct 20206 yrsCrisprbits Private Limited
Vijaya Chandru
DIN 00914988
Director19 Oct 20206 yrsCrisprbits Private Limited
Aditya Sarda
DIN 01821191
Director19 Oct 20206 yrsCrisprbits Private Limited
Vijay Vashdev Alreja
DIN 01871499
Director18 Oct 20233 yrsCrisprbits Private Limited

People of CrisprBits

5 people are tracked at CrisprBits (5 in leadership); the tracked headcount is 41.

NameRoleGroup
Co-FounderLeadership
Co-FounderLeadership
Co-FounderLeadership
Co-FounderLeadership
Co-FounderLeadership
Premium access

Complete people profiles for CrisprBits

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of CrisprBits

Figures of Crisprbits Private Limited, the primary company behind CrisprBits, for FY 2026. Revenue was ₹1.12 Cr (+35% year on year). Net loss was -₹2.30 Cr (-267% margin). EBITDA was -₹3.59 Cr (-418% margin). Revenue has grown at a compounded annual rate of +38% over three years and +451% over five years.

  • ₹1.12 CrRevenue · FY 2026 · +35% YoY
  • -₹2.30 CrNet loss · -267% margin
  • -₹3.59 CrEBITDA · -418% margin
  • ₹39.5 LakhPaid-up capital
  • +38%Revenue CAGR, 3 years
  • +451%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Crisprbits Private Limited are on its company page.

Premium access

Detailed financial statements for CrisprBits

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of CrisprBits

3 dated milestones of CrisprBits across 5 years, from founding to its latest funding, stage changes and deals.

  1. Founded CrisprBits is founded.
  2. Funding First funding round of $197K.
  3. Funding Latest funding round, Seed, of $3.0M.

Web traffic of CrisprBits

The website of CrisprBits (crisprbits.com) receives about 2.3K visits a month.

  • Monthly visits
    2.3K

    ▲ 38.4% vs previous month

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Crisprbits

Premium access

Complete news archive for CrisprBits

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about CrisprBits

CrisprBits was founded in 2020 and raised its 1st funding round 2 years after it was founded.

CrisprBits is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.

CrisprBits is a funded company, having raised a total of $3.45M across 3 funding rounds to date. The company's 1st funding round was a Seed of $196.67K, raised on May 2022.

CrisprBits has 41 employees.

The primary company behind CrisprBits, Crisprbits Private Limited, reported revenue of β‚Ή1.12 Cr for FY 2026, up 35% year on year.

CrisprBits was founded in 2020 in Delhi, India, within the biotechnology sector. Diagnostic tests utilizing CRISPR gene editing technology are provided for infectious diseases, inherited conditions, cancer detection, and genetic disease prediction. These tools are applied in animal and cell models, agriculture, biofuels production, therapeutic development, and industrial processes. Operations focus on advancing accessible diagnostics across healthcare and related fields.

CrisprBits offers CRISPR Diagnostics, Therapeutics Development, and Climate Applications.

CrisprBits has 10 investors. Key investors include VJ Technologies, Abilities India Pistons and Rings, Rajeev Kohli, Sunil Arora, and Aditya Sarda.

The valuation of CrisprBits is $284.02K as of May 2022.

CrisprBits operates through Crisprbits Private Limited.

The legal entities of CrisprBits currently have 4 directors, including Sunil Arora, Vijaya Chandru, Aditya Sarda and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available